iRadimed Quarterly Balance Sheet
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
iRadimed financial position
As of Jun 30, 2026, iRadimed reported total assets of $115.0 million, up 8.0% from a year earlier against total liabilities of $13.2 million. Shareholders' equity stood at $101.7 million, or 88.5% of assets. The company held $59.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 9.46, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
iRadimed balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 59.08M | 56.37M | 51.16M | 56.53M | 53.00M | 50.33M | 52.23M | 51.72M | 48.54M | 45.13M | 49.76M | 46.75M |
| Receivables | 13.19M | 13.41M | 13.67M | 13.86M | 10.92M | 12.71M | 10.56M | 10.36M | 11.95M | 13.03M | 12.22M | 12.78M |
| Inventory | 12.26M | 11.88M | 11.62M | 11.73M | 11.20M | 10.56M | 10.40M | 11.25M | 12.07M | 12.70M | 12.82M | 11.67M |
| Total Current Assets | 86.72M | 86.42M | 81.20M | 84.92M | 77.37M | 75.14M | 75.24M | 74.29M | 73.58M | 71.89M | 76.00M | 71.93M |
| Property, Plant & Equipment | 24.21M | 24.23M | 23.86M | 23.79M | 22.94M | 20.38M | 16.81M | 14.16M | 10.47M | 9.45M | 9.29M | 8.89M |
| Intangible Assets | 3.44M | 3.29M | 3.38M | 3.37M | 3.37M | 3.26M | 3.10M | 2.89M | 2.75M | 2.67M | 2.52M | 2.46M |
| Total Assets | 114.97M | 114.39M | 108.78M | 114.72M | 106.45M | 101.73M | 98.33M | 94.25M | 89.95M | 88.01M | 92.16M | 87.41M |
| Accounts Payable | 1.85M | 2.18M | 1.82M | 2.33M | 1.90M | 2.59M | 1.90M | 1.40M | 1.12M | 1.29M | 1.86M | 2.78M |
| Total Current Liabilities | 9.16M | 12.12M | 10.18M | 12.80M | 8.81M | 8.47M | 8.51M | 8.06M | 7.46M | 7.62M | 16.33M | 7.88M |
| Total Liabilities | 13.23M | 15.88M | 14.16M | 16.37M | 12.15M | 11.68M | 11.51M | 10.81M | 10.28M | 11.89M | 20.74M | 12.84M |
| Shareholders' Equity | 101.75M | 98.51M | 94.62M | 98.35M | 94.30M | 90.06M | 86.82M | 83.43M | 79.67M | 76.12M | 71.42M | 74.57M |
| Retained Earnings | 70.15M | 67.49M | 64.23M | 66.34M | 62.93M | 59.32M | 56.79M | 53.55M | 50.40M | 47.39M | 43.26M | 46.69M |
| Net Cash (Debt) | 59.08M | 56.37M | 51.16M | 56.53M | 53.00M | 50.33M | 52.23M | 51.72M | 48.54M | 45.13M | 49.76M | 46.75M |
| Shares Outstanding | 12.79M | 12.78M | 12.78M | 12.72M | 12.72M | 12.72M | 12.71M | 12.67M | 12.67M | 12.66M | 12.66M | 12.60M |
This table shows 12 quarterly periods of iRadimed's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IRMD's reporting calendar. What is a balance sheet?